Evercore ISI raised the firm’s price target on Procter & Gamble (PG) to $190 from $170 and keeps an Outperform rating on the shares. Procter remains the “steadiest and most balanced grower” among U.S. health and personal care stocks, says the analyst, whose mid-quarter read points to potential upside in Q4 sales. Better price-mix appear to be driving a sequential improvement in U.S. retail sales that, in turn, suggests consumer traction for the innovation Procter rolled out in April, the firm added. Operationally, Procter is winning most significantly at Walmart (WMT), but the shares’ relative performances do not reflect this reality, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Looking For Exposure to Walmart Stock (WMT)? Try These Two ETFs
- Looking for Exposure to Walmart Stock (WMT) Post Q1 Earnings? Try These Two ETFs
- Insider Sales Shake Verizon, JPMorgan, Adobe, P&G, Strategy
- Insider Moves: Procter & Gamble, Strategy, Merck, Bristol-Myers, AGNC
- UPS downgraded, ServiceNow upgraded: Wall Street’s top analyst calls